In our primary study, we found that the number of CD4+ T cells in the peripheral blood of CLL patients was elevated, and that therapy reduced the aberrant ratio of these cells.10 However, our one year follow-up of Rai stage III and IV CLL patients showed no significant change in the number of peripheral CD4+ and CD8+ T cells. Here, CD8A is linked to B-cell chronic lymphocytic leukemia.